NOW

***Update***

We thank you for your generous donations! Your support has helped us achieve our goal of raising 1000 Euros for four European cancer patient associations.

We can’t stop NOW!

Want to make your donation go even further? Please share our campaign on your social media platforms (Facebook, Instagram, LinkedIn, Twitter), to help us continue to spread awareness, and raise even more funds! Remember to tag us (TRANSMIT), the cancer patient associations (listed below), and link the campaign website (https://www.ideaginger.it/progetti/now.html).

ALL DONATIONS will be equally distributed between the four cancer patient associations:

1. 1) A.G.E.O.P. Ricerca;
2. ÖKKH;
3. Bröstcancerföreningen Amazona;
4. HLRCC.

***

Being researchers

We love our job. Scientific research is essential for the well-being of society, and the work we and other scientists all over the world do affects many aspects of our everyday life.

However, quite often it takes many years to collect the results from our research with no immediate effect on the patients. The timing of research and the immediate needs of patients separates the fight against cancer into two worlds: with researchers on one hand, and people dealing with this disease every single day on the other.

With this crowdfunding campaign, we want to bridge this gap! But, to reach this goal, we need your help Now! 

Two worlds, one common goal

To us researchers, fighting cancer means studying the biology of this disease to discover new and more effective treatments to defeat cancer.

Outside of research there are many other people involved in this fight. Among these people are the patient associations that help cancer patients deal with cancer: by providing accurate and trustworthy information, professional and peer counseling, and through organizing recreational activities.

Despite working separately, we feel very close to these associations, who are operating at the front line with the patients. For this reason, we have launched this crowdfunding campaign. We want to do something concrete and immediate to support the activities carried out by 4  European associations committed to helping cancer patients and their families.

A network of researchers working for a network of associations: we want to bring the world of scientific research closer to the world of patients. We fight a common enemy in different ways, and we want to know the faces and the stories of the people we are trying to help with our research. Together we are stronger! 

Which associations we will help

The funds that we will raise, thanks to your help, will be equally distributed between the following patient associations: 

• A.G.E.O.P. Ricerca (Parent Association for Hematology Pediatric Oncology) - Bologna, Italy
• ÖKKH (Austrian Childhood Cancer Organisation) - Vienna, Austria
• Bröstcancerföreningen Amazona (Breast Cancer Society) - Stockholm, Sweden
• HLRCC (Hereditary Leiomyomatosis and RCC) Family Alliance (VHL Alliance Project supported by “VHL UK/Ireland” registered charity) - UK/Ireland
  

Why supporting us

As part of the European project: TRANSMIT (Translating the role of Mitochondria in Tumorigenesis), all eleven of us aim to contribute to the development of new treatments for people suffering from cancer.

Patient associations are absolutely essential in conveying our (and other) research to patients, among the many other forms of support offered by these associations.

Support our campaign! And help us become a bridge capable of uniting all those involved in the fight against cancer. Donate now! 

The TRANSMIT project

TRANSMIT is a European project that investigates the role of mitochondria in the development of cancer, with a specific focus on effective ways of communicating the progress of scientific research to the general public. 9 European partners collaborate on the project: the University of Bologna, the Université catholique de Louvain, the Justus-Liebig-University of Giessen, the University Hospital of the Paracelsus Medical University Salzburg, the Karolinska Institute, the University of Cambridge, the University of Bordeaux, Oroboros Instruments and BIOCRATES Life Sciences.